Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome
Authors
James J. Anderson (ORCID: https://orcid.org/0000-0003-4124-3466)
Hormuzd A. Katki (ORCID: https://orcid.org/0000-0003-2002-0095)
Stephanie J. Lee (ORCID: https://orcid.org/0000-0003-2600-6390)
Sharon Savage (ORCID: https://orcid.org/0000-0002-6477-5222)
Abraham Aviv (ORCID: https://orcid.org/0000-0002-7441-0227)
John E. Levine (ORCID: https://orcid.org/0000-0002-5611-7828)
Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome
James J. Anderson, Hormuzd A. Katki, Stephanie J. Lee, Sharon Savage et al.
Citations
6 citations
Journal
EBioMedicine
Topics
Telomeres, Telomerase, and Senescence
Field-Weighted Citation Impact (FWCI)
6.99
article
Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome
James J. Anderson, Hormuzd A. Katki, Stephanie J. Lee, Sharon Savage, Abraham Aviv, John E. Levine, Wael Saber, Caitrin Bupp, Paul Livermore Auer, Kyra Jennifer Waligora Mendez, Casey Dagnall, Stephen R. Spellman, Shahinaz M. Gadalla, Tsung-Po Lai, Amy Hutchinson, Valerie Stewart
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 114
Institutions
Rutgers, The State University of New Jersey (US), National Marrow Donor Program (US), University of Washington (US), Medical College of Wisconsin (US), National Cancer Institute (US), Division of Cancer Epidemiology and Genetics, Icahn School of Medicine at Mount Sinai (US)